The Overlooked Semiconductor Stock Poised to Lead in the AI Race

Camtek reported record Q2 revenue of $133 million, up 8% year over year, and expects Q3 revenue of roughly $159 million, implying about 20% sequential growth. The semiconductor inspection-equipment supplier expects second-half revenue to rise 25% versus the first half, including approximately 45% growth in advanced-packaging revenue, supported by HBM4 memory investment and AI chip demand. Camtek holds about 60% share in advanced-packaging inspection, though its valuation remains elevated at roughly 184x trailing earnings; analysts' $190 median target implies 42% upside.

Analysis

CAMT is a high-beta expression of HBM and advanced-packaging capex rather than a broad AI-equipment proxy. Its earnings setup is unusually sensitive to tool acceptance and shipment timing: a deferred qualification at one large memory customer can shift quarterly revenue materially while leaving the longer-cycle demand narrative intact. The market will therefore reward evidence of backlog conversion and gross-margin durability more than headline order growth over the next 1-3 months.

The key competitive question is whether CAMT can defend pricing as packaging lines migrate from capacity additions to yield optimization. KLAC, AMAT and ONTO have broader installed bases and customer-service leverage; any share gain by those players, or a customer dual-sourcing decision, would compress CAMT's premium multiple before it visibly affects reported revenue. Conversely, successful HBM4 yield ramps raise inspection intensity per package, creating a favorable mix effect that could make consensus 2027 earnings too conservative.

The recent drawdown makes the stock less vulnerable to a simple valuation reset, but it remains exposed to a memory-capex air pocket if HBM supply catches up faster than AI accelerator demand. The contrarian view is that investors may be treating advanced packaging as a single, uninterrupted cycle: the more likely path is volatile quarterly bookings alongside sustained 6-18 month content growth. A recovery thesis is falsified by sequential backlog contraction, gross margin falling despite higher revenue, or MU/TSM signaling reduced 2027 HBM and advanced-packaging capital intensity.

Key Decisions for Investors

• Initiate a starter long CAMT only after the next earnings release confirms sequential backlog growth and stable/improving gross margin; target a 15-25% move over 3-6 months on 2027 estimate revisions, with a 10-12% stop if bookings or guidance fail to validate conversion.
• Express the idiosyncratic thesis as long CAMT / short ONTO in equal semiconductor-equipment beta through the next two earnings cycles. CAMT wins if HBM-specific packaging inspection demand outpaces broader metrology spend; exit if ONTO reports stronger advanced-packaging bookings or CAMT's service/installation execution slips.
• Maintain a 1-3 month watch on MU guidance, TSM advanced-packaging commentary and HBM pricing. Any indication that memory makers are pulling forward rather than expanding 2027 capex argues against adding CAMT, even if its near-term revenue guide remains strong.
• For portfolios requiring defined downside, use a 6-9 month CAMT call spread rather than outright shares after confirmation of order conversion; the structure limits exposure to another multiple compression while retaining upside from a 2027 backlog-driven rerating.